(Q83932911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Management of adult patients with ascites due to cirrhosis: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Bruce A Runyon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

AASLD Practice Guidelines Committee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

1 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

2087-2107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers

29 January 2020

cites work

1 reference

7 January 2021

Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization

1 reference

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

7 January 2021

Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis.

1 reference

7 January 2021

Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.

1 reference

7 January 2021

Natural history of patients hospitalized for management of cirrhotic ascites

1 reference

7 January 2021

The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites

1 reference

7 January 2021

Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study

1 reference

7 January 2021

Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases

1 reference

7 January 2021

Care of patients with ascites

1 reference

7 January 2021

Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

1 reference

7 January 2021

Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease

1 reference

7 January 2021

Performance standards for therapeutic abdominal paracentesis

1 reference

7 January 2021

Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No.

1 reference

7 January 2021

Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management

1 reference

7 January 2021

Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit

1 reference

7 January 2021

The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.

1 reference

7 January 2021

Choosing the location for non-image guided abdominal paracentesis

1 reference

7 January 2021

Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy

1 reference

7 January 2021

Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips

1 reference

7 January 2021

Strips and tubes: improving the diagnosis of spontaneous bacterial peritonitis

1 reference

7 January 2021

Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis

1 reference

7 January 2021

Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis

1 reference

7 January 2021

Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis

1 reference

7 January 2021

Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation

1 reference

7 January 2021

Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis

1 reference

7 January 2021

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites

1 reference

7 January 2021

Ascitic fluid analysis in malignancy-related ascites

1 reference

7 January 2021

Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis

1 reference

7 January 2021

Use of magnetic enrichment for detection of carcinoma cells in fluid specimens

1 reference

7 January 2021

Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States

1 reference

7 January 2021

1 reference

7 January 2021

Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis

1 reference

7 January 2021

Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing

1 reference

7 January 2021

Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection

1 reference

7 January 2021

Electrolyte studies on patients with cirrhosis of the liver

1 reference

7 January 2021

Hyponatremia in cirrhosis: Results of a patient population survey.

1 reference

7 January 2021

Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases

1 reference

7 January 2021

A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial

1 reference

7 January 2021

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

1 reference

7 January 2021

Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites

1 reference

7 January 2021

Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety

1 reference

7 January 2021

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites

1 reference

7 January 2021

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

1 reference

7 January 2021

METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES

1 reference

7 January 2021

Use of Metolazone in the Treatment of Ascites due to Liver Disease

1 reference

7 January 2021

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

7 January 2021

Furosemide-induced natriuresis as a test to identify cirrhotic patients with refractory ascites

1 reference

7 January 2021

The significance of the furosemide test for predicting ascites control by diuretics in cirrhotics: a comparison with volume expansion and octreotide infusion

1 reference

7 January 2021

Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial

1 reference

7 January 2021

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema

1 reference

7 January 2021

Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites

1 reference

7 January 2021

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

1 reference

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

7 January 2021

Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis

1 reference

7 January 2021

ALTERATIONS IN ALBUMIN METABOLISM AFTER SERUM AND ALBUMIN INFUSIONS.

1 reference

7 January 2021

The effect of repeated albumin infusions in patients with cirrhosis

1 reference

7 January 2021

Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat

1 reference

7 January 2021

Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement

1 reference

7 January 2021

Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions.

1 reference

7 January 2021

Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study

1 reference

7 January 2021

Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.

1 reference

7 January 2021

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

1 reference

7 January 2021

A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

7 January 2021

The North American Study for the Treatment of Refractory Ascites

1 reference

7 January 2021

Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis.

1 reference

7 January 2021

A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

1 reference

7 January 2021

Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites: Effects in patients with organic or functional renal failure

1 reference

7 January 2021

Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study.

1 reference

7 January 2021

Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents

1 reference

7 January 2021

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

7 January 2021

The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension

1 reference

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

7 January 2021

TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.

1 reference

7 January 2021

Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites.

1 reference

7 January 2021

Use of subcutaneous venous access ports to treat refractory ascites

1 reference

7 January 2021

Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study

1 reference

7 January 2021

Chronic albumin infusions to achieve diuresis in patients with ascites who are not candidates for transjugular intrahepatic portosystemic shunt (TIPS).

1 reference

7 January 2021

Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system

1 reference

7 January 2021

Comparative pilot study of repeated large volume paracentesis vs the combination on clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites

1 reference

7 January 2021

Octreotide in the treatment of refractory ascites of cirrhosis

1 reference

7 January 2021

Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study

1 reference

7 January 2021

Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

1 reference

7 January 2021

Continuous hemofiltration in the treatment of acute renal failure

1 reference

7 January 2021

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

1 reference

7 January 2021

Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome

1 reference

7 January 2021

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome

1 reference

7 January 2021

Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study

1 reference

7 January 2021

Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study

1 reference

7 January 2021

Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study

1 reference

7 January 2021

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

1 reference

7 January 2021

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome

1 reference

7 January 2021

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

1 reference

7 January 2021

Meta-analysis: terlipressin therapy for the hepatorenal syndrome

1 reference

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

7 January 2021

Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.

1 reference

7 January 2021

Good news for hepatorenal syndrome

1 reference

7 January 2021

Recovery from “Hepatorenal Syndrome” after Orthotopic Liver Transplantation

1 reference

7 January 2021

Spontaneous bacterial peritonitis

1 reference

7 January 2021

Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis

1 reference

7 January 2021

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

1 reference

7 January 2021

Effect of marked peripheral leukocytosis on the leukocyte count in ascites

1 reference

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

7 January 2021

Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis

1 reference

7 January 2021

Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis

1 reference

7 January 2021

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients

1 reference

7 January 2021

Five Days of Ceftriaxone to Treat Culture Negative Neutrocytic Ascites in Cirrhotic Patients

1 reference

7 January 2021

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

7 January 2021

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

1 reference

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

7 January 2021

Restricted use of albumin for spontaneous bacterial peritonitis

1 reference

7 January 2021

A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.

1 reference

7 January 2021

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

1 reference

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

7 January 2021

Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.

1 reference

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

7 January 2021

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

1 reference

7 January 2021

Improved survival after variceal bleeding in patients with cirrhosis over the past two decades

1 reference

7 January 2021

Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

1 reference

7 January 2021

Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis

1 reference

7 January 2021

An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis

1 reference

7 January 2021

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

7 January 2021

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

1 reference

7 January 2021

Bacterial and fungal infections after liver transplantation: an analysis of 284 patients

1 reference

7 January 2021

Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.22853

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19475696%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference